QIAGEN Q2 Profit Rises

August 05, 2026 — 06:02 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - QIAGEN N.V. (QGEN) on Wednesday reported higher second-quarter earnings, while the molecular diagnostics company reaffirmed its full-year 2026 outlook.

Net income for the quarter increased to $103.4 million, or $0.50 per share, from $96.3 million, or $0.44 per share, a year ago. Adjusted earnings rose to $0.62 per share from $0.60.

Net sales were $535.0 million, compared with $533.5 million in the prior-year quarter. Growth in Sample Technologies, Genomics/NGS and QuantiFERON sales was offset by declines in Diagnostic Solutions, PCR/Nucleic Acid Amplification and other product categories.

For fiscal 2026, QIAGEN reaffirmed its outlook for constant exchange rate net sales growth of about 1% to 2% and adjusted earnings of at least $2.43 per share.

For the third quarter, the company expects constant exchange rate sales growth of about 1% to 2% and adjusted earnings of at least $0.62 per share.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

QIAGEN Q2 Profit Rises

Tags

Latest Articles